Cargando…
Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life
Objective: Evaluate bioequivalence, based on norelgestromin (NGMN) and ethinyl estradiol (EE) plasma concentrations, and adhesion of a transdermal contraceptive patch containing a newly sourced adhesive component (test) at end of shelf life (EOSL) vs. the marketed EVRA patch (reference) at beginning...
Autores principales: | Sanga, Madhu, Vaughan, Subusola, Nangosyah, Julius, Scholz, Veronika, Fonseca, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670371/ https://www.ncbi.nlm.nih.gov/pubmed/34779392 http://dx.doi.org/10.5414/CP204034 |
Ejemplares similares
-
Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
por: Alissa, Ibrahim, et al.
Publicado: (2023) -
Mathematical Modeling of the Release of Active Ingredients from a Contraceptive Patch: Ortho Evra(®) as a Case Study
por: Trujillo-de Santiago, Grissel, et al.
Publicado: (2014) -
Shelf Life and Storage Conditions of Universal Adhesives: A Literature Review
por: Iliev, Georgi, et al.
Publicado: (2021) -
Formulation and Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Colchicine
por: Lei, Yaran, et al.
Publicado: (2022) -
Shelf life /
por: Man, Dominic
Publicado: (2002)